Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.

Nakanjako, D; Ssinabulya, I; Nabatanzi, R; Bayigga, L; Kiragga, A; Joloba, M; Kaleebu, P; Kambugu, AD; Kamya, MR; Sekaly, R; +2 more... Elliott, A; Mayanja-Kizza, H; (2015) Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial. Tropical medicine & international health, 20 (3). pp. 380-90. ISSN 1360-2276 DOI: https://doi.org/10.1111/tmi.12442

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1111/tmi.12442

Abstract

Share

Download

Filename: emss-64546.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar